SHANNON KLEINSCHMIDT: Open Payments
NPI 1164123725 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,926 in 45 payments from 16 companies in 2025. Trend: 2023 $1,039 · 2024 $2,180 · 2025 $1,926
Food & beverage: $1,842Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $559 |
| Madrigal Pharmaceuticals | 5 | $289 |
| QOL Medical, LLC | 3 | $183 |
| Enterra Medical, Inc. | 1 | $160 |
| PFIZER INC. | 7 | $151 |
| Mallinckrodt Hospital Products Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $118 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| Lilly USA, LLC | 1 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: TREMFYA, REZDIFFRA, Sucraid, VELSIPITY, TERLIVAZ, Wegovy, IQIRVO, ZEPBOUND.
Industry payments across AZ — which companies pay providers there.
